{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:04Z","timestamp":1792715884628,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,3,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>MYD88 L265P is expressed in WM and IgM MGUS patients using AS-PCR assays with potential use in diagnostic discrimination and response assessment.<\/jats:p>","DOI":"10.1182\/blood-2012-09-454355","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T00:51:00Z","timestamp":1358297460000},"page":"2051-2058","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":364,"title":["MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction"],"prefix":"10.1182","volume":"121","author":[{"given":"Lian","family":"Xu","sequence":"first","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Morra","sequence":"additional","affiliation":[{"name":"Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Trojani","sequence":"additional","affiliation":[{"name":"Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Greco","sequence":"additional","affiliation":[{"name":"Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, University of Pavia Medical School and Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Varettoni","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, University of Pavia Medical School and Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tzu","family":"Tai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"},{"name":"Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"},{"name":"Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"},{"name":"Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Manning","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina K.","family":"Tripsas","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal I.","family":"Lindeman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"},{"name":"Department of Pathology, Brigham and Women's Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstr\u00f6m\u2019s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111809382247600_B1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia.","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"key":"2019111809382247600_B2","first-page":"194","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"issue":"9","key":"2019111809382247600_B3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia.","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111809382247600_B4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas.","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"issue":"21","key":"2019111809382247600_B5","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.1307.1307","article-title":"MYD88 L265P mutation in Waldenstrom\u2019s macroglobulinemia [abstract].","volume":"120","author":"Poulain","year":"2012","journal-title":"Blood"},{"key":"2019111809382247600_B6","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in patients with Waldenstrom macroglobulinemia, IgM monoclonal gammopathy of undetermined significance or other mature B-cell neoplasms.","author":"Varettoni"},{"issue":"21","key":"2019111809382247600_B7","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.2699.2699","article-title":"MYD88 pathway activation in lymphoplasmacytic lymphoma drives tumor cell growth and cytokine expression [abstract].","volume":"120","author":"Ansell","year":"2012","journal-title":"Blood"},{"issue":"7332","key":"2019111809382247600_B8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma.","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"issue":"9","key":"2019111809382247600_B9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma.","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"7354","key":"2019111809382247600_B10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"6","key":"2019111809382247600_B11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00401-011-0891-2","article-title":"Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.","volume":"122","author":"Montesinos-Rongen","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2019111809382247600_B12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.icb.7100095","article-title":"Structure, function and regulation of the Toll\/IL-1 receptor adaptor proteins.","volume":"85","author":"Watters","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"41","key":"2019111809382247600_B13","doi-asserted-by":"crossref","first-page":"28093","DOI":"10.1074\/jbc.M109.004465","article-title":"Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.","volume":"284","author":"Loiarro","year":"2009","journal-title":"J Biol Chem"},{"issue":"7300","key":"2019111809382247600_B14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling.","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"issue":"6","key":"2019111809382247600_B15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ni.1606","article-title":"Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.","volume":"9","author":"Kawagoe","year":"2008","journal-title":"Nat Immunol"},{"issue":"6699","key":"2019111809382247600_B16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/26254","article-title":"IKAP is a scaffold protein of the IkappaB kinase complex.","volume":"395","author":"Cohen","year":"1998","journal-title":"Nature"},{"key":"2019111809382247600_B17","author":"Yang"},{"issue":"15","key":"2019111809382247600_B18","article-title":"Participation of BTK in MYD88 signaling in malignant cells expressing the L265P mutation in Waldenstrom\u2019s macroglobulinemia, and effect on tumor cells with BTK-inhibitor PCI-32765 in combination with MYD88 pathway inhibitors.","volume":"30","author":"Yang","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111809382247600_B19","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1182\/blood-2007-09-115170","article-title":"Targeting NF-kappaB in Waldenstrom macroglobulinemia.","volume":"111","author":"Leleu","year":"2008","journal-title":"Blood"},{"issue":"9","key":"2019111809382247600_B20","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.exphem.2007.05.022","article-title":"Establishment of BCWM.1 cell line for Waldenstr\u00f6m\u2019s macroglobulinemia with productive in vivo engraftment in SCID-hu mice.","volume":"35","author":"Ditzel Santos","year":"2007","journal-title":"Exp Hematol"},{"issue":"19","key":"2019111809382247600_B21","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1182\/blood-2010-12-326868","article-title":"Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.","volume":"117","author":"Hodge","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111809382247600_B22","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"10","key":"2019111809382247600_B23","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.","volume":"102","author":"Kyle","year":"2003","journal-title":"Blood"},{"issue":"9","key":"2019111809382247600_B24","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/sj.leu.2403442","article-title":"Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.","volume":"18","author":"Morra","year":"2004","journal-title":"Leukemia"},{"issue":"21","key":"2019111809382247600_B25","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1200\/JCO.2005.06.147","article-title":"Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom\u2019s macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.","volume":"23","author":"Baldini","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019111809382247600_B26","first-page":"30","article-title":"Use of whole genome sequencing to identify highly recurrent somatic mutations in Waldenstr\u00f6m\u2019s macroglobulinemia.","volume":"\u25aa\u25aa\u25aa","author":"Hunter","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111809382247600_B27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.2011.08726.x","article-title":"Attainment of complete\/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia.","volume":"154","author":"Treon","year":"2011","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111809382247600_B28","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","article-title":"Quantitative PCR of bone marrow BCL2\/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.","volume":"105","author":"Rambaldi","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2019111809382247600_B29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/annonc\/mdn044","article-title":"Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.","volume":"19","author":"Arcaini","year":"2008","journal-title":"Ann Oncol"},{"issue":"2","key":"2019111809382247600_B30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3324\/haematol.11671","article-title":"High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.","volume":"93","author":"Montoto","year":"2008","journal-title":"Haematologica"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/11\/2051\/1364574\/2051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/11\/2051\/1364574\/2051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T10:34:15Z","timestamp":1574073255000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/11\/2051\/31090\/MYD88-L265P-in-Waldenstr%C3%B6m-macroglobulinemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,3,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-09-454355","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}